US 11306095
Use of pteridinone derivative serving as EGFR inhibitor
granted A61KA61K31/519A61P
Quick answer
US patent 11306095 (Use of pteridinone derivative serving as EGFR inhibitor) held by East China University of Science and Technology expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- East China University of Science and Technology
- Grant date
- Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/519, A61P, A61P35/00, A61P35/02